SCHEMBL24968634

SCHEMBL24968634

Cc1nnc(COc2ccc(-c3nnc(Nc4ccc5[nH]ncc5c4)[nH]3)cc2Cl)o1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 3/20 0.36
▸ ROCK2 O75116 4/20 0.36
▸ KDR P35968 5/20 0.36
▸ AURKA O14965 2/20 0.36
▸ DAPK3 O43293 2/20 0.36
▸ JAK2 O60674 2/20 0.36
▸ PRKD3 O94806 2/20 0.36
▸ MAP4K4 O95819 2/20 0.36
▸ PAK4 O96013 2/20 0.36
▸ NTRK1 P04629 2/20 0.36
▸ LCK P06239 2/20 0.36
▸ FYN P06241 2/20 0.36
▸ CSF1R P07333 2/20 0.36
▸ IGF1R P08069 2/20 0.36
▸ MET P08581 2/20 0.36
▸ FGFR1 P11362 2/20 0.36
▸ PDGFRA P16234 2/20 0.36
▸ PRKACA P17612 2/20 0.36
▸ FLT1 P17948 2/20 0.36
▸ LTK P29376 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22967232 0.90 RET (0.44) RETROCK2KDRIGF1RTNIK
SCHEMBL22966858 0.87 CACNA2D1 (0.43) ROCK2KDRGSK3AROCK1CLK4
SCHEMBL24610311 0.85 AGPAT2 (0.42) RETROCK2KDRAURKADAPK3
SCHEMBL22966914 0.79 ROCK1 (0.52) ROCK2CLK2ROCK1DYRK1ACLK4
SCHEMBL24610310 0.79 ROCK2 (0.39) ROCK2KDRDAPK3PRKD3MAP4K4
SCHEMBL24094235 0.77 NPC1 (0.44) RETROCK2KDRWEE1ALK
SCHEMBL24610278 0.75 RET (0.48) RETROCK2KDRIGF1RROCK1
SCHEMBL24094106 0.73 ROCK2 (0.47) RETROCK2KDRGSK3AROCK1
SCHEMBL24094169 0.73 NPC1 (0.55) ROCK2KDRFGFR1GSK3AROCK1
SCHEMBL24094280 0.72 RET (0.42) RETROCK2KDRAURKADAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230021916-A1 MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE REDX PHARMA LIMITED (GB) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021916-A1 MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE ROCK2, ROCK1, RHOA RET 1721/4885ROCK2 1/4885KDR 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback